Jessica Ann Chacon

Title: Jessica Ann Chacon: Innovator in Cancer Therapy

Introduction

Jessica Ann Chacon is a prominent inventor based in Philadelphia, PA (US). She has made significant contributions to the field of cancer therapy, particularly through her innovative methods for expanding tumor-infiltrating lymphocytes for adoptive cell therapy. With a total of 2 patents, her work is paving the way for advancements in cancer treatment.

Latest Patents

One of her latest patents is focused on the enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapy. This method involves culturing tumor fragments from the subject in a culture medium containing IL-2 and a 41BB agonist. The goal is to expand tumor-infiltrating lymphocytes with enriched tumor-reactivity and specificity. Additionally, the patent discloses a method for treating a tumor in a subject, which includes administering nonmyeloablative lymphodepleting chemotherapy and the expanded tumor-infiltrating lymphocytes.

Career Highlights

Jessica has worked with notable institutions such as the H. Lee Moffitt Cancer Center and Research Institute, Inc. and the Board of Regents of the University of Texas. Her work in these organizations has allowed her to develop and refine her innovative approaches to cancer treatment.

Collaborations

Some of her notable coworkers include Jeffrey S. Weber and James J. Mulé. Their collaboration has contributed to the advancement of research in cancer therapies.

Conclusion

Jessica Ann Chacon is a trailblazer in the field of cancer therapy, with her innovative methods showing great promise for future treatments. Her contributions are vital in the ongoing fight against cancer, and her patents reflect her dedication to improving patient outcomes.